Molecular evolutionary analysis predicts the incidence of hepatocellular carcinoma in the United States and Japan (original) (raw)

Abstract

Long-term serial serum samples containing hepatitis C virus (HCV) from the US and Japan were molecularly clocked to determine the time-origin of the HCV epidemic. Based on the molecular clock that held significantly, it is estimated that HCV genotype 1 first appeared in the US around 1910 whereas in Japan HCV surfaced before 1882. By regression analyses and coalescent theory, widespread dissemination of HCV in the US population occurred during the 1960s, approximately 30 years later than in Japan. Currently, the prevalence of hepatocellular carcinoma (HCC) is strikingly higher in Japan than in the US. If HCC is a function of increased HCV exposure time, the molecular clock predicts that the burden of HCC in the US will accelerate in the next two to three decades.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abe K, Inchauspe G, Fujisawa K (1992) Genomic characterization and mutation rate of hepatitis C virus isolated from a patient who contracted hepatitis during an epidemic of non-A, non-B hepatitis in Japan. J Gen Virol 73:2725
    CAS PubMed Google Scholar
  2. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G (1989) Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321:1494
    CAS PubMed Google Scholar
  3. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS (1999) The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341:556
    Article CAS PubMed Google Scholar
  4. Armstrong GL, Alter MJ, McQuillan GM, Margolis HS (2000) The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 31:777
    Article CAS PubMed Google Scholar
  5. Center for Disease Control and Prevention (1998) Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity Mortality Weekly Rep 47:RR-19
    Google Scholar
  6. El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745
    Article CAS PubMed Google Scholar
  7. El-Serag HB, Mason AC (2000) Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 160:3227
    Article CAS PubMed Google Scholar
  8. Iida F, Iida R, Kamijo H, Takaso K, Miyazaki Y, Funabashi W, Tsuchiya K, Matsumoto Y (1999) Chronic Japanese schistosomiasis and hepatocellular carcinoma: ten years of follow-up in Yamanashi Prefecture, Japan. Bull World Health Organ 77:573
    CAS PubMed Google Scholar
  9. Ina Y, Mizokami M, Ohba K, Gojobori T (1994) Reduction of synonymous substitutions in the core protein gene of hepatitis C virus. J Mol Evol 38:50
    Google Scholar
  10. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671
    CAS PubMed Google Scholar
  11. Moriya T, Koyama T, Tanaka J, Mishiro S, Yoshizawa H (1999) Epidemiology of hepatitis C virus in Japan. Intervirology 42:153
    Article CAS PubMed Google Scholar
  12. Nair S, Shivakumar KS, Thuluvath PJ (2002) Mortality from hepatocellular and biliary cancers: changing epidemiological trends. Am J Gastroenterol 97:167
    PubMed Google Scholar
  13. Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, Tsuji T, Yano M, Kuo G, Choo QL (1991) A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 67:429
    CAS PubMed Google Scholar
  14. Ogata N, Alter HJ, Miller RH, Purcell RH (1991) Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A 88:3392
    Google Scholar
  15. Okamoto H, Kojima M, Okada S, Yoshizawa H, Iizuka H, Tanaka T, Muchmore EE, Peterson DA, Ito Y, Mishiro S (1992) Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 190:894
    Article CAS PubMed Google Scholar
  16. Pybus OG, Rambaut A, Harvey PH (2000) An integrated framework for the inference of viral population history from reconstructed genealogies. Genetics 155:1429
    CAS PubMed Google Scholar
  17. Pybus OG, Charleston MA, Gupta S, Rambaut A, Holmes EC, Harvey PH (2001) The epidemic behavior of the hepatitis C virus. Science 292:2323
    Article CAS PubMed Google Scholar
  18. Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, Teratani T, Tohgo G, Toda N, Ohashi M (1995) Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology 22:1027
    Article CAS PubMed Google Scholar
  19. Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T, Alter HJ (2002) Inaugural Article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 99:15584
    Google Scholar

Download references

Acknowledgements

We would like to thank Dr. H.J. Alter and Dr. J.W.K. Shih from the Department of Transfusion Medicine, Warren Grant Magnuson Clinical Center, National Institute of Health, USA, and Dr. T. Gojobori and Dr. K. Hanaka from the Center for Information Biology, National Institute of Genetics, Japan.

Author information

Authors and Affiliations

  1. Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences, Kawasumi, Mizuho, Nagoya 467-8601, Japan
    Masashi Mizokami & Yasuhito Tanaka

Authors

  1. Masashi Mizokami
  2. Yasuhito Tanaka

Corresponding author

Correspondence toMasashi Mizokami.

Additional information

This work was presented at the 19th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium, “State of the Arts for Digestive Organs”, 14–15 November 2003, Nagoya, Japan.

Rights and permissions

About this article

Cite this article

Mizokami, M., Tanaka, Y. Molecular evolutionary analysis predicts the incidence of hepatocellular carcinoma in the United States and Japan.Cancer Chemother Pharmacol 54 (Suppl 1), S83–S86 (2004). https://doi.org/10.1007/s00280-004-0892-0

Download citation

Keywords